White matter disease and cognitive impairment in FMR1 premutation carriers

Neurology

Volumn 84, Issue 21, 2015, Pages 2146-2152

  Filley, Christopher M ^a,b,f   Brown, Mark S ^c   Onderko, Karen ^e   Ray, Megan ^e   Bennett, Rachael E ^d   Berry Kravis, Elizabeth ^g,h,i   Grigsby, Jim ^d,e  

^a Departments of Neurology   (United States)

^b Departments of Psychiatry   (United States)

^c Departments of Radiology   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g Departments of Neurological Sciences   (United States)

^h Department of Pediatrics ^*  (United States)

ⁱ RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; FRAGILE X MENTAL RETARDATION PROTEIN; N ACETYLASPARTIC ACID; FMR1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BEHAVIORAL DYSCONTROL SCALE; BRAIN DISEASE; CLINICAL ARTICLE; COGNITION ASSESSMENT; COGNITIVE DEFECT; CONTROLLED ORAL WORD ASSOCIATION TEST; CONTROLLED STUDY; CORPUS CALLOSUM; CROSS-SECTIONAL STUDY; DIFFUSION TENSOR IMAGING; EXECUTIVE FUNCTION; FRACTIONAL ANISOTROPY; FRAGILE X SYNDROME; FUNCTIONAL ASSESSMENT; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; MIDDLE CEREBELLAR PEDUNCLE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROCESSING SPEED WITH THE SYMBOL DIGIT MODALITIES TEST; WHITE MATTER; WHITE MATTER DISEASE; ATAXIA; CEREBELLUM; FEMALE; GENETICS; LEUKOENCEPHALOPATHY; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TREMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATAXIA; CEREBELLUM; COGNITION DISORDERS; CORPUS CALLOSUM; CROSS-SECTIONAL STUDIES; DIFFUSION TENSOR IMAGING; EXECUTIVE FUNCTION; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; TREMOR;

EID: 84929862816     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001612     Document Type: Article

References (34)

1. Leehey M. A. Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med 2009;57:830-836.
2. Grigsby J, Brega AG, Engle K, et al. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology 2008;22:48-60.
3. Hunter JE, Sherman S, Grigsby J, Kogan C, Cornish K. Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts. Neuropsychology 2011;26:156-164.
4. Grigsby J, Cornish K, Hocking D, et al. The cognitive neuropsychological phenotype of carriers of the FMR1 premutation. J Neurodev Disord 2014;6:28.
5. Seritan AL, Nguyen DV, Farias ST, et al. Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1138-1144.
6. Kraan CM, Hocking DR, Georgiou-Karistianis N, et al. Impaired response inhibition is associated with selfreported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers. Am J Med Genet B Neuropsychiatr Genet 2014;165B:41-51.
7. Filley CM. White matter dementia. Ther Adv Neurol Disord 2012;5:267-277.
8. Greco CM, Berman RF, Martin RM, et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 2006;129:243-255.
9. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging. Am J Hum Genet 2003;72:869-878.
10. Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain 2011;134:863-878.
11. Bacalman S, Farzin F, Bourgeois JA, et al. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatr 2006;67:87-94.
12. Grigsby J, Kaye K, Robbins LJ. Reliabilities, norms, and factor structure of the Behavioral Dyscontrol Scale. Percept Mot Skills 1992;74:883-892.
13. Spreen O, Benton AL. Neurosensory Center Comprehensive Examination for Aphasia (NCCEA), revised edition. Victoria: University of Victoria Neuropsychology Laboratory; 1977.
14. Smith A. The Symbol Digit Modalities Test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord 1968;3:83-91.
15. FolsteinMF, Folstein S, McHugh PR. "Mini-Mental State": a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
17. IBM Corp. IBM SPSS Statistics for Macintosh, version 22.0. Armonk, NY: IBM Corp.; 2013.
18. Brega AG, Goodrich G, Bennett RE, et al. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. J Clin Exp Neuropsychol 2008;30:853-869.
19. Hashimoto R, Srivastava S, Tassone F, Hagerman RJ, Rivera SM. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov Disord 2011;26:1329-1336.
20. Middeldorp J, Hol EM. GFAP in health and disease. Prog Neurobiol 2011;93:421-443.
21. Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 2013;12:786-798.
22. Ross-Inta C, Omanska-Klusek A, Wong S, et al. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J 2010;429:545-552.
23. Napoli E, Ross-Inta C, Wong S, et al. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet 2011;20:3079-3092.
24. Pfefferbaum A, Sullivan EV, Hedehus M, Lim KO, Adalsteinsson E. Age-related decline in brain white matter anisotropy measured with spatially corrected echoplanar diffusion tensor imaging. Magn Reson Med 2000;44:259-268.
25. Pagani E, Agosta F, Rocca M. A, Caputo D, Filippi M. Voxel-based analysis derived from fractional anisotropy images of white matter volume changes with aging. Neuroimage 2008;41:657-667.
26. Ardekani S, Kumar A, Bartzokis G, Sinha U. Exploratory voxel-based analysis of diffusion indices and hemispheric asymmetry in normal aging. Magn Reson Imaging 2007; 25:154-167.
27. Grigsby J, Kaye K, Shetterly SM, Baxter J, Morgenstern NE, Hamman RF. Prevalence of disorders of executive cognitive functioning among the elderly: findings from the San Luis Valley Health and Aging Study. Neuroepidemiology 2002; 21:213-220.
28. Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum: insights from the clinic Cerebellum 2007;6:254-267.
29. Stoodley CJ, Schmahmann JD. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 2010; 46:831-844.
30. Apartis E, Blancher A, Meissner WG, et al. FXTAS: new insights and the need for revised diagnostic criteria. Neurology 2012;79:1898-1907.
31. Kraan CM, Hocking DR, Bradshaw JL, et al. Symbolic sequence learning is associated with cognitive-affective profiles in female FMR1 premutation carriers. Genes Brain Behav 2014;13:385-393.
32. Battistella G, Niederhauser J, Fornari E, et al. Brain structure in asymptomatic FMR1 premutation carriers at risk for fragile X-associated tremor/ataxia syndrome. Neurobiol Aging 2013;34:1700-1707.
33. Wang JY, Hagerman RJ, Rivera SM. A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers. Mov Disord 2013;28:1278-1284.
34. Berry-Kravis E, Hall DA. Executive dysfunction in young FMR1 premutation carriers: forme fruste of FXTAS or new phenotype? Neurology 2011;77:612-613.